COMMENT While last week’s announcement is disappointing, we believe that BACE inhibitors still hold promise in stopping the accumulation of amyloid and preventing the clinical onset of Alzheimer’s disease—particularly in healthy people who are at increased risk ...
JOB 2018-05-21 Employer Washington University School of Medicine Principal Investigator Carlos Cruchaga Description A postdoctoral research fellow position is available immediately at the Cruchaga lab at the Washington University School of Medicine. The lab is part of ...
JOB 2018-05-21 Employer Washington University Principal Investigator Carlos Cruchaga Description Washington University is seeking applicant for a postdoc position to work in the lab of Drs. Cruchaga and Harari at the School of Medicine. The goal of their research is to ...
NYU School of MedicineNew York, United States
Weill CornellNew York, United States
Heidi Jacobs, Jasmeer Chhatwal, Jennifer Rabin on Cerebrovascular Disease: Does Tau Mediate Cognitive Decline?
COMMENT This is an interesting study with well-characterized patient groups exploring the cross-sectional relationship between subcortical small vessel disease, amyloid, and tau deposits in patients with subcortical vascular cognitive impairment. Using ...
CONFERENCE 2018-09-03 00:00:00-2018-09-14 00:00:00 Barcelona, Spain 03 – 14 September 2018 View Conference Website 1 ...
PAPER Goschorska M, Baranowska-Bosiacka I, Gutowska I, Tarnowski M, Piotrowska K, Metryka E, Safranow K, Chlubek D
Effect of acetylcholinesterase inhibitors donepezil and rivastigmine on the activity and expression of cyclooxygenases in a model of the inflammatory action of fluoride on macrophages obtained from THP-1 monocytes.Toxicology. 2018 May 16; PubMed: 29777723
PAPER Jiao W, Wang Y, Kong L, Ou-Yang T, Meng Q, Fu Q, Hu Z
CART peptide activates the Nrf2/HO-1 antioxidant pathway and protects hippocampal neurons in a rat model of Alzheimer's disease.Biochem Biophys Res Commun. 2018 May 16; PubMed: 29777699
PAPER Marioni RE, Harris SE, Zhang Q, McRae AF, Hagenaars SP, Hill WD, Davies G, Ritchie CW, Gale CR, Starr JM, Goate AM, Porteous DJ, Yang J, Evans KL, Deary IJ, Wray NR, Visscher PM29777097
PAPER Betthauser TJ, Cody KA, Zammit MD, Murali D, Converse AK, Barnhart TE, Stone CK, Rowley HA, Johnson SC, Christian BT
In vivo characterization and quantification of neurofibrillary tau PET radioligand [18 F]MK-6240 in humans from Alzheimer's disease dementia to young controls.J Nucl Med. 2018 May 18; PubMed: 29777006
No filters selected